Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 195

Similar articles for PubMed (Select 17700366)

1.

Functional effects of protein sequence polymorphisms in the organic cation/ergothioneine transporter OCTN1 (SLC22A4).

Urban TJ, Yang C, Lagpacan LL, Brown C, Castro RA, Taylor TR, Huang CC, Stryke D, Johns SJ, Kawamoto M, Carlson EJ, Ferrin TE, Burchard EG, Giacomini KM.

Pharmacogenet Genomics. 2007 Sep;17(9):773-82.

PMID:
17700366
2.

Functional genetic diversity in the high-affinity carnitine transporter OCTN2 (SLC22A5).

Urban TJ, Gallagher RC, Brown C, Castro RA, Lagpacan LL, Brett CM, Taylor TR, Carlson EJ, Ferrin TE, Burchard EG, Packman S, Giacomini KM.

Mol Pharmacol. 2006 Nov;70(5):1602-11. Epub 2006 Aug 24.

3.

Functional genetic variation in the basal promoter of the organic cation/carnitine transporters OCTN1 (SLC22A4) and OCTN2 (SLC22A5).

Tahara H, Yee SW, Urban TJ, Hesselson S, Castro RA, Kawamoto M, Stryke D, Johns SJ, Ferrin TE, Kwok PY, Giacomini KM.

J Pharmacol Exp Ther. 2009 Apr;329(1):262-71. doi: 10.1124/jpet.108.146449. Epub 2009 Jan 13.

4.

Discovery of the ergothioneine transporter.

Gründemann D, Harlfinger S, Golz S, Geerts A, Lazar A, Berkels R, Jung N, Rubbert A, Schömig E.

Proc Natl Acad Sci U S A. 2005 Apr 5;102(14):5256-61. Epub 2005 Mar 28.

5.

Substrate discrimination by ergothioneine transporter SLC22A4 and carnitine transporter SLC22A5: gain-of-function by interchange of selected amino acids.

Bacher P, Giersiefer S, Bach M, Fork C, Schömig E, Gründemann D.

Biochim Biophys Acta. 2009 Dec;1788(12):2594-602. doi: 10.1016/j.bbamem.2009.09.019. Epub 2009 Oct 6.

6.
7.

Genetic variations of the SLC22A4 gene in Chinese and Indian populations of Singapore.

Toh DS, Koo SH, Limenta LM, Yee JY, Murray M, Lee EJ.

Drug Metab Pharmacokinet. 2009;24(5):475-81.

8.

Gene knockout and metabolome analysis of carnitine/organic cation transporter OCTN1.

Kato Y, Kubo Y, Iwata D, Kato S, Sudo T, Sugiura T, Kagaya T, Wakayama T, Hirayama A, Sugimoto M, Sugihara K, Kaneko S, Soga T, Asano M, Tomita M, Matsui T, Wada M, Tsuji A.

Pharm Res. 2010 May;27(5):832-40. doi: 10.1007/s11095-010-0076-z. Epub 2010 Mar 12.

PMID:
20224991
9.

Probing the substrate specificity of the ergothioneine transporter with methimazole, hercynine, and organic cations.

Grigat S, Harlfinger S, Pal S, Striebinger R, Golz S, Geerts A, Lazar A, Schömig E, Gründemann D.

Biochem Pharmacol. 2007 Jul 15;74(2):309-16. Epub 2007 Apr 22.

PMID:
17532304
10.

Epitope shared by functional variant of organic cation/carnitine transporter, OCTN1, Campylobacter jejuni and Mycobacterium paratuberculosis may underlie susceptibility to Crohn's disease at 5q31.

Lamhonwah AM, Ackerley C, Onizuka R, Tilups A, Lamhonwah D, Chung C, Tao KS, Tellier R, Tein I.

Biochem Biophys Res Commun. 2005 Dec 2;337(4):1165-75. Epub 2005 Oct 6.

PMID:
16246312
11.

Novel localization of OCTN1, an organic cation/carnitine transporter, to mammalian mitochondria.

Lamhonwah AM, Tein I.

Biochem Biophys Res Commun. 2006 Jul 14;345(4):1315-25. Epub 2006 May 12.

PMID:
16729965
12.

Functional characterization of ergothioneine transport by rat organic cation/carnitine transporter Octn1 (slc22a4).

Nakamura T, Yoshida K, Yabuuchi H, Maeda T, Tamai I.

Biol Pharm Bull. 2008 Aug;31(8):1580-4.

13.

Decreased proliferation and erythroid differentiation of K562 cells by siRNA-induced depression of OCTN1 (SLC22A4) transporter gene.

Nakamura T, Sugiura S, Kobayashi D, Yoshida K, Yabuuchi H, Aizawa S, Maeda T, Tamai I.

Pharm Res. 2007 Sep;24(9):1628-35. Epub 2007 Apr 20.

PMID:
17447122
14.
15.

Effects of genetic variation in the novel organic cation transporter, OCTN1, on the renal clearance of gabapentin.

Urban TJ, Brown C, Castro RA, Shah N, Mercer R, Huang Y, Brett CM, Burchard EG, Giacomini KM.

Clin Pharmacol Ther. 2008 Mar;83(3):416-21. Epub 2007 Jul 4.

PMID:
17609685
16.

The human OCTN1 (SLC22A4) reconstituted in liposomes catalyzes acetylcholine transport which is defective in the mutant L503F associated to the Crohn's disease.

Pochini L, Scalise M, Galluccio M, Pani G, Siminovitch KA, Indiveri C.

Biochim Biophys Acta. 2012 Mar;1818(3):559-65. doi: 10.1016/j.bbamem.2011.12.014. Epub 2011 Dec 21.

17.

Transport of drugs in the kidney by the human organic cation transporter, OCT2 and its genetic variants.

Fujita T, Urban TJ, Leabman MK, Fujita K, Giacomini KM.

J Pharm Sci. 2006 Jan;95(1):25-36. Review.

PMID:
16307453
18.

Structural and functional characteristics and tissue distribution pattern of rat OCTN1, an organic cation transporter, cloned from placenta.

Wu X, George RL, Huang W, Wang H, Conway SJ, Leibach FH, Ganapathy V.

Biochim Biophys Acta. 2000 Jun 1;1466(1-2):315-27.

19.

Organic cation transporter-mediated ergothioneine uptake in mouse neural progenitor cells suppresses proliferation and promotes differentiation into neurons.

Ishimoto T, Nakamichi N, Hosotani H, Masuo Y, Sugiura T, Kato Y.

PLoS One. 2014 Feb 25;9(2):e89434. doi: 10.1371/journal.pone.0089434. eCollection 2014.

20.

Polymorphisms in a human kidney xenobiotic transporter, OCT2, exhibit altered function.

Leabman MK, Huang CC, Kawamoto M, Johns SJ, Stryke D, Ferrin TE, DeYoung J, Taylor T, Clark AG, Herskowitz I, Giacomini KM; Pharmacogenetics of Membrane Transporters Investigators.

Pharmacogenetics. 2002 Jul;12(5):395-405.

PMID:
12142729
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk